"Ospedale di Alta Specialità a Cotignola, in provincia di Ravenna, accreditato con il Servizio Sanitario Nazionale. Per maggiori informazioni e prenotazioni visita il sito web."

During the past decade, Maria Cecilia Hospital conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 4 clinical trials were completed, i.e. on average, 12.1% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 4 clinical trials were completed. i.e. 23.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maria Cecilia Hospital" #1 sponsor was "Ettore Sansavini Health Science Foundation" with 8 trials, followed by "Maria Cecilia Hospital" with 7 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored and "CID - Carbostent & Implantable Devices" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maria Cecilia Hospital" #1 collaborator was "Ettore Sansavini Health Science Foundation" with 3 trials as a collaborator, "Bard Ltd" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Cardiovascular Research Foundation Clinical Trials Center" with 1 trials as a collaborator and "Cedars-Sinai Medical Center" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Maria Cecilia Hospital" are "Critical Limb Ischemia" (4 trials), "Peripheral Arterial Disease" (4 trials), "Aortic Valve Disease" (3 trials), "Coronary Artery Disease" (3 trials) and "Peripheral Artery Disease" (3 trials). Many other conditions were trialed in "Maria Cecilia Hospital" in a lesser frequency.

Most popular intervention types in "Maria Cecilia Hospital" are "Device" (23 trials), "Procedure" (11 trials), "Other" (5 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Boston Scientific Cardiac Cryoablation System" (2 trials), "Multiple arterial grafting" (2 trials), "Single arterial graft" (2 trials), "Acute normovolemic hemodilution" (1 trials) and "Amino Acids" (1 trials). Other intervention names were less common.

The vast majority of trials in "Maria Cecilia Hospital" are 43 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Maria Cecilia Hospital". 1 are not yet recruiting, 11 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Maria Cecilia Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Maria Cecilia Hospital, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 23 trials that are defined as “Not Applicable".